Magro, F., Santos-Antunes, J., Vilas-Boas, F., Rodrigues-Pinto, E., et al. (2014). Crohn's disease outcome in patients under azathioprine: A tertiary referral center experience. Journal of Crohn's and Colitis, 8(7), 617 - 625.

Magro, F., Santos-Antunes, J., Albuquerque, A., Vilas-Boas, F., et al. (2013). Epstein-barr virus in inflammatory bowel disease-correlation with different therapeutic regimens. Inflammatory Bowel Diseases, 19(8), 1710 - 1716.

Abreu, C., Magro, F., Vilas-Boas, F., Lopes, S., et al. (2013). Listeria infection in patients on anti-TNF treatment: Report of two cases and review of the literature. Journal of Crohn's and Colitis, 7(2), 175 - 182.

Abreu, C., Magro, F., Santos-Antunes, J., Pilão, A., et al. (2013). Tuberculosis in anti-TNF-? treated patients remains a problem in countries with an intermediate incidence: Analysis of 25 patients matched with a control population. Journal of Crohn's and Colitis, 7(10), e486 - e492.

Campos, N., Magro, F., Castro, A. R., Cabral, J., et al. (2011). Macrophages from IBD patients exhibit defective tumour necrosis factor-? secretion but otherwise normal or augmented pro-inflammatory responses to infection. Immunobiology, 216(8), 961 - 970.